EPTRI was present at the Horizon4Poland’22 Conference held last November 22. Bonka Georgieva from our Coordination Team has participated at the break out session “How to boost Innovation with EU funds through public private partnership”, alongside with Nathalie...
The 2nd International Meet on Public Health and Healthcare Management will be held on December 5 – 7, 2022 in London, UK. At this congress the most recent public health and healthcare management development will be discussed by scientific experts in the field. The...
Biosimilars approved in the EU are interchangeable. The EU experts on biosimilar medicines (Biosimilar Medicines Working Party or BMWP) and the Heads of Medicines’ Agencies (HMA) Biosimilar Working Group have drafted a joint statement explaining the rationale for...
This conference entitled “Launch of Charter for EU Cooperation to Enable Safe and Timely Patient Access to Advanced Therapies in Europe” has been organized by the TRANSFORM MEP Interest Group of the European Alliance for Transformative Therapies. The in-person event...
The 20th International Conference on Pharmaceutical Medicine – ICPM, an event on biomedical science, pharmaceutical research and technology under the theme “What lies ahead in Pharmaceutical Medicine” will be held next week, on October 19th until the 21st, in Athens...
Cystic fibrosis (CF) is a life-shortening, monogenic, autosomal-recessive disorder, and has an estimated incidence of 1:2500 to 1:3500 live births. Newborn screening (NBS) has been implemented for CF in many European countries, Australia, New Zealand, Canada, and...
This important report has been published by the Council for International Organizations of Medical Sciences (CIOMS) Working Group XI. The report combines the experience and expertise of the CIOMS Working Group XI on Patient involvement in the development, regulation,...
The 2022-2026 Workplan of the Accelerate Clinical Trials in the EU (ACT EU) initiative has been published by the European Commission (EC), the Heads of Medicines Agencies (HMA), and the European Medicines Agency (EMA). The ACT EU, launched on January 2022, seeks to...
The webinar is organized by the European CRO Federation (EUCROF) and it will be held online on October 5th from 10:00 to 11:30 am (CEST). People-centered clinical trials are a growing concept in Clinical Trials, so it is crucial to foresee and develop initiatives...
The US Food and Drug Administration (FDA) has approved Bluebird Bio’s one-time beta-thalassaemia treatment Zynteglo, also known as betibeglogene autotemcel (beti-cel), as the first cell-based gene therapy for the treatment of patients with beta-thalassaemia who...